The #AIEYE #Podcast
- #Medtech #Stocks: GBT Technologies' (OTC: $GTCH) CTO Discusses the
Significance of FDA Approval for the #qTerm Human Vital Signs Device;
#artificialintelligence
Point
Roberts WA, Vancouver BC – January 28, 2021
– Investorideas.com (www.investorideas.com), a global investor
news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye, featuring
technology company GBT Technologies Inc. (OTCPINK:GTCH).
Listen to today’s
podcast:
https://www.investorideas.com/Audio/Podcasts/2021/012521-GTCH-qTerm.mp3
Read this in full
at https://www.investorideas.com/news/2021/artificial-intelligence/01281GTCH-FDA-Approval-qTerm.asp
GBT
Technologies Inc. (OTC
PINK:GTCH)
recently announced that GBT Tokenize
Corp, its joint venture, is now seeking approval for its qTerm human vital
signs device with the United States Food and Drug Administration (FDA). In an
interview with Investorideas.com, GBT’s CTO, Danny Rittman, explained that the
rigour of the FDA approval process was necessary and beneficial to the product.
“We
are expecting some improvements and modifications because during the process of
the FDA approval – and with their own guidelines and standards – we may
definitely need to do some,” he said. “That’s something we’re looking forward
to, because that’s only going to make the device better, more accurate and more
credentialed. The more credentials we get for the device, the better for us.
That’s the plan.”
FDA
approval will also grant the qTerm legitimacy in the eyes of consumers, Rittman
explained in a recent press release:
“Another aspect is
to gain potential customer's confidence and trust in the product's performance
and accuracy. We plan to offer the technology for personal, hospital and
clinical usage [in] seeking to comply with the industry's standards and
regulations.”
Rittman
clarified however, that approval from the FDA is not essential but rather that
the company was pursuing it to expand future market opportunities.
“FDA
approval is not a must for qTerm, we voluntarily do this certification in order
to bring the device to a clinical level which can open a whole world of
possibilities marketing wise (clinics, hospitals, etc…),” he said. “The device
can be introduced to the market as is in many other wearables that are not
defined as a “medical device”, if for ramification only.”
In
its first release, the qTerm will boast the abilities to measure body
temperature, blood oxygen level and heart rate. GBT Tokenize will subsequently
add blood pressure to this and these functions will be accompanied by a
smartphone app and web application that will keep a history for the user's
records, providing a geographical proximity alert and record statistical data
about the user's vitals.
“In addition the device measures ambient
temperatures to notify the user about an efficient measurement environment for
accuracy purposes.” Rittman added.
While
there are other mobile health detection devices out there, the qTerm is
distinguished by its being powered by GBT’s AI technology. Rittman indicated in
the press release:
“…we believe that
its main advantage upon similar products is its Artificial Intelligence
technology that offers advanced features like real-time health statistics,
analytics, and monitoring.”
“The
AI will basically collect the data, track it, keep a history and will alert
personally, per person in case of abnormalities,” he said. “Assuming a person
takes, on a daily basis, their blood pressure, oxygen level or heart rate
… the AI engine will notice differences … and the user is going to get
notifications.”
From the press
release: “Early detection of potential health issues, based on vitals can be
crucial and a life saver. Applying for an FDA clearance is a long process but
we strongly believe it will bring our technology to the highest standards to be
used by hospitals and individuals.”
Sam Mowers, Investorideas.com
Read and hear other editions of the AI
Eye
For a list of artificial intelligence stocks on Investorideas.com visit here
Investors can trade these stocks and other
ideas on our site using our list
of top stock trading apps
including Robinhood , Acorn,
Stash and others.
About GBT
Technologies Inc.
GBT
Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a
development-stage company which considers itself a native IoT creator,
developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled
mobile technology platforms. GBT has a
portfolio of Intellectual Property that, when commercialized, will include
smart microchips, mobile and security applications and protocols, and
supporting cloud software. GBT’s system
envisions the creation of a global mesh network. The core of the system will be its advanced
microchip technology that can be installed in any mobile or fixed device
worldwide. GBT envisions this system as a low-cost, secure, private mesh
network between any enabled devices, providing shared processing, advanced
mobile database management/sharing and enhanced mobile features as an alternative
to traditional carrier services.
About Investorideas.com
- News that Inspires Big Investing Ideas Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports
biotech, water, renewable energy and more. Investor Idea’s original branded
content includes the following podcasts and columns : Crypto
Corner , Play by Play sports and
stock news column, Investor Ideas Potcasts Cannabis
News and Stocks on the Move podcast and column, Cleantech and Climate Change , Exploring Mining the AI Eye
.
The Investorideas.com podcasts are also available on iTunes, Spotify, Tunein, Stitcher, Spreaker.com,
iHeartRadio and Google Play Music.
Visit the Podcast page at Investorideas.com:
https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and
our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Disclosure:
GTCH is a paid for featured AI stock on Investorideas.com
Global
investors must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye- Watching stock news,
deal tracker and advancements in artificial intelligence is an original
content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Download our Mobile App for iPhone
and Android
Join our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800 665 0411
Get more Technology
stock investor ideas - news, articles, podcasts
and stock directories
No comments:
Post a Comment